Introducing AGED Diagnostics
Active Genomes Expressed
Welcome. We’re AGED Diagnostics, and we’re disrupting the hepatology industry using genomic innovation! Our technology has been recognized by market leaders and our scalable business model is setting the trend for industry standards. Curious to find out more? Browse through our website, and get in touch if you would like to request a demo.
Hepatologists (who diagnose and treat disease of the liver) can identify patients high risk for developing liver cancer, but the invasiveness and cost of current diagnostic tests lead many patients to drop out of monitoring programs. AGED’s product will provide physicians a method to keep patients in the monitoring program for early detection, intervention and improved outcomes for patients and their families.
UNMET MEDICAL NEEDS
Hepatocellular Carcinoma (HCC or liver cancer) is the fastest growing cancer both worldwide and in the US. The current blood tests for HCC are less than 60% accurate and often fail to detect tumors at an early stage, and more accurate imaging alternatives are expensive.
These challenges mean most patients are diagnosed at late stages, at which time patient outcomes are poor and mortality rates are high and healthcare spending can cost up to $1,000,000 per patient. AGED is addressing these pain points by developing a diagnostic tool with a keen focus on early detection.
WHAT WE DO
AGED Diagnostics is developing the most accurate blood test for liver cancer to help hepatologists improve patient outcomes and reduce the financial burden on health insurers. AGED’s solution will be more cost-effective than other approaches, and be able to diagnose liver cancer earlier than other methods at a time when treatment is most effective.
AGED technology targets multiple clinically relevant markers to increase sensitivity and specificity. Liver cancer has a handful of underlying causes, while current biomarkers do not capture these differences, AGED is building our design using the intricacies necessary to capture differences between patient populations.
Meet The Team
AGED Core Team
Founder & CEO
Managing Scientific Director